ketoacidosis

(redirected from DKA)
Also found in: Dictionary, Thesaurus, Medical, Acronyms.

ketoacidosis

[‚kēd·ō‚as·ə′dō·səs]
(medicine)
Mentioned in ?
References in periodicals archive ?
Blood concentrations of D-lactate are increased in diabetes, and particularly in DKA in humans (3).
Tumor hucreleri desmin ile fokal, myogenin ile diffuz pozitif reaksiyon verirken, CD34, S100, DKA ile negatif reaksiyon verdi.
Thus brain function may be relatively normal, until hyperglycaemia, acidosis and dehydration are severe, or if onset of DKA was abrupt.
Verilerin tanimlayici analizleri yapildiktan sonra basvuruda DKA tablosunda olanlar (Grup 1) ile diger hastalar (Grup 2) Pearson ki-kare analizi ve Student's t-test kullanilarak karsilastirildi.
The American Diabetes Association (ADA) guidelines consider DKA under control when blood glucose is < 200 mg/dL, bicarbonate is greater than 18 mEq/L and pH is > 7.
Raltegravir, the only INSTI to be approved for clinical use to date, is a member of the hydroxypyrimidinone carboxamide class of inhibitors, and although structurally different from DKAs, is mechanistically similar [26].
We conclude that, in severe DKA when intravenous access is unattainable, the IO route will permit the efficient and safe administration of insulin and that the IO route is likely to be a superior means of administration than subcutaneous or intramuscular administration in those with dehydration resulting in compromised peripheral perfusion.
A draft environmental white paper report was prepared by DKA and contains a summary of findings of fact, conclusions and recommendations for mitigating any asbestos or other health, safety, or environmental risks associated with the proposed tear-off shingles recycling demonstration.
Of note, both cases of DKA were of classic presentation, with blood glucose values above 350 mg/dL at the time of hospitalization.
This test provides the opportunity for early recognition of DKA symptoms, a potentially life threatening yet preventable complication of diabetes.
Insulin therapy is not recommended unless underlying DKA is present.
Some data suggest that type 1 diabetes patients with mild DKA can be managed with subcutaneous rapid-acting insulin analogues in an outpatient setting (Diabetes Care 2004;27:1873-8), but it is unknown if symptomatic, mild hyperglycemia in type 2 diabetes patients can be managed adequately in such settings, said certified diabetes educator Becky Armor, Pharm.